115 related articles for article (PubMed ID: 11597732)
1. Upstream mediators of the Fas apoptotic transduction pathway are defective in B-chronic lymphocytic leukemia.
Roué G; Lancry L; Duquesne F; Salaün V; Troussard X; Sola B
Leuk Res; 2001 Nov; 25(11):967-80. PubMed ID: 11597732
[TBL] [Abstract][Full Text] [Related]
2. Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecules expression.
de Totero D; Montera M; Rosso O; Clavio M; Balleari E; Foa R; Gobbi M
Hematol J; 2004; 5(2):152-60. PubMed ID: 15048066
[TBL] [Abstract][Full Text] [Related]
3. Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release.
Raisova M; Bektas M; Wieder T; Daniel P; Eberle J; Orfanos CE; Geilen CC
FEBS Lett; 2000 May; 473(1):27-32. PubMed ID: 10802053
[TBL] [Abstract][Full Text] [Related]
4. Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation.
Jones DT; Ganeshaguru K; Virchis AE; Folarin NI; Lowdell MW; Mehta AB; Prentice HG; Hoffbrand AV; Wickremasinghe RG
Blood; 2001 Nov; 98(9):2800-7. PubMed ID: 11675354
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of CD95 (Fas/Apo-1) on T cells of patients with B-cell chronic lymphocytic leukemia.
Groneberg C; Pickartz T; Binder A; Ringel F; Srock S; Sieber T; Schoeler D; Schriever F
Exp Hematol; 2003 Aug; 31(8):682-5. PubMed ID: 12901972
[TBL] [Abstract][Full Text] [Related]
6. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.
MacFarlane M; Harper N; Snowden RT; Dyer MJ; Barnett GA; Pringle JH; Cohen GM
Oncogene; 2002 Oct; 21(44):6809-18. PubMed ID: 12360407
[TBL] [Abstract][Full Text] [Related]
8. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade.
Juo P; Kuo CJ; Yuan J; Blenis J
Curr Biol; 1998 Sep; 8(18):1001-8. PubMed ID: 9740801
[TBL] [Abstract][Full Text] [Related]
9. B cell receptor cross-linking triggers a caspase-8-dependent apoptotic pathway that is independent of the death effector domain of Fas-associated death domain protein.
Besnault L; Schrantz N; Auffredou MT; Leca G; Bourgeade MF; Vazquez A
J Immunol; 2001 Jul; 167(2):733-40. PubMed ID: 11441077
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G
J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1.
Inaba H; Shimada K; Zhou YW; Ido M; Buck S; Yonehara S; Kaplan J; Komada Y
Int J Oncol; 2005 Aug; 27(2):573-9. PubMed ID: 16010441
[TBL] [Abstract][Full Text] [Related]
13. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
[TBL] [Abstract][Full Text] [Related]
14. Fas/FasL signaling allows extracelluar-signal regulated kinase to regulate cytochrome c release in oridonin-induced apoptotic U937 cells.
Liu YQ; Mu ZQ; You S; Tashiro S; Onodera S; Ikejima T
Biol Pharm Bull; 2006 Sep; 29(9):1873-9. PubMed ID: 16946501
[TBL] [Abstract][Full Text] [Related]
15. Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice.
Yoshida T; Higuchi T; Hagiyama H; Strasser A; Nishioka K; Tsubata T
Int Immunol; 2000 Apr; 12(4):517-26. PubMed ID: 10744653
[TBL] [Abstract][Full Text] [Related]
16. Oxidized low density lipoprotein potentiation of Fas-induced apoptosis through lectin-like oxidized-low density lipoprotein receptor-1 in human umbilical vascular endothelial cells.
Imanishi T; Hano T; Sawamura T; Takarada S; Nishio I
Circ J; 2002 Nov; 66(11):1060-4. PubMed ID: 12419941
[TBL] [Abstract][Full Text] [Related]
17. Etoposide-induced apoptosis is not associated with the fas pathway in acute myeloblastic leukemia cells.
Siitonen T; Mäntymaa P; Säily M; Savolainen E; Koistinen P
Leuk Res; 2000 Apr; 24(4):281-8. PubMed ID: 10713325
[TBL] [Abstract][Full Text] [Related]
18. Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis.
Gamberale R; Geffner J; Arrosagaray G; Scolnik M; Salamone G; Trevani A; Vermeulen M; Giordano M
Leukemia; 2001 Dec; 15(12):1860-7. PubMed ID: 11753606
[TBL] [Abstract][Full Text] [Related]
19. Qualitative and quantitative characterization of Fas (APO-1/CD95) on leukemic cells derived from patients with B-cell neoplasms.
Tsuruda K; Yamada Y; Hirakata Y; Sugahara K; Maeda T; Atogami S; Tomonaga M; Kamihira S
Leuk Res; 1999 Feb; 23(2):159-66. PubMed ID: 10071131
[TBL] [Abstract][Full Text] [Related]
20. Humoral immunodeficiency in chronic lymphocytic leukemia: role of CD95/CD95L in tumoral damage and escape.
Sampalo A; Brieva JA
Leuk Lymphoma; 2002 Apr; 43(4):881-4. PubMed ID: 12153179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
